Quantcast

Latest Artificial kidney Stories

2014-05-23 04:20:47

LAUSANNE, Switzerland, May 23, 2014 /PRNewswire/ -- Debiotech, AWAK and Neokidney Development sign partnership to bring compact home haemodialysis machine to first patients by 2017 Today three international innovators join forces to develop and deliver to patients the world's first portable artificial kidney. Debiotech of Switzerland, AWAK of Singapore and Neokidney Development, an initiative of the Dutch Kidney Foundation, have signed a joint venture agreement to...

2013-12-02 23:24:09

ChinaMarketResearchReports.com adds “Global and China Hemodialysis Industry Report, 2012-2013” latest report to its store. Dallas, TX (PRWEB) December 02, 2013 Hemodialysis is also regarded as artificial kidney, a kind of blood purification targeting mainly at the treatment of renal failure patients. In 2011, the global dialysis population hit 2.158 million, a year-on-year increase of 6.4%. And the growth rate is estimated to maintain around 6% in the upcoming years, with the targeted...

2011-07-29 13:11:56

A sudden drop in blood pressure while undergoing dialysis has long vexed many kidney patients. Side effects associated with this situation over the long term range from stroke to seizure to heart damage to death. Patients also suffer in the short term with gastrointestinal, muscular and neurologic symptoms. Now one more disturbing side effect can be been added to this list. A study led by researchers at the Stanford University School of Medicine reports an increased risk of blood clotting at...

2011-03-01 06:00:00

CAMBRIDGE, Mass., March 1, 2011 /PRNewswire/ -- Pervasis Therapeutics, Inc. announced today that the European Commission (EC) has granted Orphan Drug Designation for Vascugel® for the prevention of hemodialysis vascular access failure in patients with end stage renal disease (ESRD). The designation follows a positive opinion from The Committee for Orphan Medicinal Products (COMP) within the European Medicines Agency (EMA) earlier this year. Vascugel is a novel...

2011-02-08 07:30:00

CAMBRIDGE, Mass., Feb. 8, 2011 /PRNewswire/ -- Pervasis Therapeutics announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track review status for Vascugel® for the prevention of hemodialysis access failure in patients with end stage renal disease (ESRD). Vascugel, a novel endothelial cell-based therapy and Pervasis' lead development program, aims to regulate the body's healing response following surgical interventions to create vascular...

2009-12-02 17:43:00

NEW YORK, Dec. 2 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Renal Disease Treatments: Products and Therapies http://www.reportlinker.com/p0166824/Renal-Disease-Treatments-Products-and-Therapies.html Forecasts for the U.S. market in products and services, providing data for 2008 and estimates for 2009, and projections for the market and compound annual growth rates (CAGRs) from 2009 to 2014 Focus on pharmaceutical...

2009-02-13 23:10:56

Dr. Willem Kolff, regarded as the father of artificial organs, has died at his home in Pennsylvania, colleagues said. He was 97. The Dutch-born physician -- who invented the first artificial kidney during World War II using sausage casings and orange juice cans -- died Wednesday, The New York Times reported. Kolff also built the first artificial heart. Dr. Kolff was a pioneer in the truest sense of the word. His groundbreaking work on the artificial kidney in the 1940s made him a household...


Word of the Day
holluschickie
  • A 'bachelor seal'; a young male seal which is prevented from mating by its herd's older males (mated bulls defending their territory).
This comes from the Russian word for 'bachelors.'
Related